Jan 24 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2019 Dec 31, 2018 Mar 31, 2020
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 3.51 3.64 5.00
(-3.4 pct) (+10.3 pct) (+7.0 pct)
Operating 559 mln 562 mln 650 mln
(-0.5 pct) (+40.2 pct) (+11.8 pct)
Recurring 561 mln 578 mln 650 mln
(-2.9 pct) (+37.2 pct) (+8.9 pct)
Net 384 mln 394 mln 450 mln
(-2.4 pct) (+44.3 pct) (+16.6 pct)
EPS 94.23 yen 98.96 yen 121.98 yen
Ann Div 15.00 yen 15.00 yen
-Q2 div NIL NIL
-Q4 div 15.00 yen 15.00 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T